Post Approval Study to Evaluate the Safety and Performance of GENTA-FOIL Resorb® in Hand Surgery

NCT ID: NCT04482140

Last Updated: 2025-11-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

15 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-10-14

Study Completion Date

2025-11-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Single arm study to evaluate the safety and performance of Genta-Foil resorb® for the prevention of tissue adhesions

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

GENTA-FOIL resorb® is an implantable, absorbable collagen barrier foil, which forms a temporary barrier between the functional structures during the critical phase of wound healing. As a result, the ability of the tissue layers to slide against each other is retained.

The objective of hand surgery is to promote wound repair, and regeneration of all motor and sensory functions of the hand and to restore the subject's hand mobility, and improve their quality of life. However, hand trauma and operations often lead to the formation of adhesions between the various tissue layers of the hand (e.g. muscles, tendons and nerves). Even with minimally invasive procedures and optimal aftercare, development of adhesions in the suture and wound areas is often unavoidable. Adhesion formation between repaired tendons and the surrounding tissue has been thought to be one of the most important factors that disturbs functional restoration. It is estimated that the adhesion, which can cause significant disability, occurs in about 30% of cases.

The purpose of this study is to investigate the use of GENTA-FOIL resorb® for the prevention of tissue adhesions measured by restoration in digital function in subjects undergoing hand surgery. The functional outcome of tendon injury after a repair depends on multiple factors such as age, injury level and type, type of repair, and post repair therapy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tissue Adhesions, Surgery-Induced

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Genta-Foil resorb®

Genta-Foil resorb® is a transparent collagen foil that forms a temporary barrier between the functional structures during the critical phase of wound healing. As a result, the ability of the tissue layers to slide against each other is retained. The absorbability of equine collagen means the foil can be left in place and does not require removal. The addition of the antibiotic Gentamicin is for self-protection since collagen implants are prone to bacterial contamination.

Genta-Foil resorb®

Intervention Type DEVICE

Use of Genta-Foil resorb® to prevent adhesions in patients undergoing hand surgery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Genta-Foil resorb®

Use of Genta-Foil resorb® to prevent adhesions in patients undergoing hand surgery

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Subject is male or female, ≥18 years of age;
2. Subject is willing and able to give written informed consent;
3. Subject is scheduled for one if the following surgical procedures:

* 3a. extensor tendon repair zones I to VI.
* 3b. flexor tendon repair zones I to VI.
* 3c. open reduction and internal fixation to repair hand fractures of proximal phalanx, and/or middle phalanx, and/or metacarpals
4. Subject is willing and able to comply with the study procedures during surgery and the post-surgical follow up period.

Exclusion Criteria

1. Subject is known to be sensitive to any of the device components e.g. Gentamicin (aminoglycosides) or equine collagen.
2. Subject is known to be non-compliant with medical treatment.
3. Subject has any known impaired renal function/autoimmune illness/neuromuscular disease (such as Parkinson's or Myasthenia Gravis).
4. Subject is currently taking an Aminoglycoside antibiotic as stand-alone treatment or in combination with other antibiotics
5. Subject is pregnant or actively breastfeeding.
6. Subject has active infection at surgical site
7. Subject has any significant or unstable medical or psychiatric condition that, in the opinion of the Investigator, would interfere with their ability to participate in the study, or affect the study outcomes.
8. Subject is currently enrolled in another clinical study that would interfere with their ability to participate in this study
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Newcastle-upon-Tyne Hospitals NHS Trust

OTHER

Sponsor Role collaborator

KAT General Hospital

OTHER

Sponsor Role collaborator

Advanced Medical Solutions Ltd.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stephen Lipscombe

Role: PRINCIPAL_INVESTIGATOR

Whiston Hospital Mersey and West Lancashire Teaching Hospitals NHS Trust, Warrington Rd, Rainhill, Prescot

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

KAT Attica General Hospital

Athens, Athens, Greece

Site Status

Whiston Hospital - Mersey and West Lancashire Teaching Hospitals Trust

Rainhill, Merseyside, United Kingdom

Site Status

Royal Victoria Infirmary Newcastle Upon Tyne NHS Foundation Trust

Newcastle upon Tyne, Tyne and Wear, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Greece United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

001GF

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Poly-4-Hydroxybutyrate Scaffold in Rhytidectomy
NCT07132892 ENROLLING_BY_INVITATION NA